Literature DB >> 1694727

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

D Viskochil1, A M Buchberg, G Xu, R M Cawthon, J Stevens, R K Wolff, M Culver, J C Carey, N G Copeland, N A Jenkins.   

Abstract

Three new neurofibromatosis type 1 (NF1) mutations have been detected and characterized. Pulsed-field gel and Southern blot analyses reveal the mutations to be deletions of 190, 40, and 11 kb of DNA. The 11 kb deletion does not contain any of the previously characterized genes that lie between two NF1 translocation breakpoints, but it does include a portion of a rodent/human conserved DNA sequence previously shown to span one of the translocation breakpoints. By screening cDNA libraries with the conserved sequence, we identified a number of cDNA clones from the translocation breakpoint region (TBR), one of which hybridizes to an approximately 11 kb mRNA. The TBR gene crosses at least one of the chromosome 17 translocation breakpoints found in NF1 patients. Furthermore, the newly characterized NF1 deletions remove internal exons of the TBR gene. Although these mutations might act by compromising regulatory elements affecting some other gene, these findings strongly suggest that the TBR gene is the NF1 gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694727     DOI: 10.1016/0092-8674(90)90252-a

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  264 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  Physical analysis of murine albino deletions that disrupt liver-specific gene regulation or mesoderm development.

Authors:  M L Klebig; B S Kwon; E M Rinchik
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 3.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 4.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 5.  Mouse models of glioblastoma: lessons learned and questions to be answered.

Authors:  Loury Janbazian; Jason Karamchandani; Sunit Das
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

6.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

7.  Congenital anomalies and genetic disorders in families of children with central nervous system tumours.

Authors:  S M Jones; P C Phillips; P T Molloy; B J Lange; M N Needle; J A Biegel
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

8.  Cerebral vasculopathy in a Chinese family with neurofibromatosis type I mutation.

Authors:  Jian-Tao Liang; Li-Rong Huo; Yu-Hai Bao; Zhen-Yu Wang; Feng Ling
Journal:  Neurosci Bull       Date:  2013-11-11       Impact factor: 5.203

Review 9.  Neurofibromatosis-related tumors: emerging biology and therapies.

Authors:  Matthias A Karajannis; Rosalie E Ferner
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

10.  A deletion in the 5'-region of the neurofibromatosis type 1 (NF1) gene.

Authors:  S Hoffmeyer; G Assum; D Kaufmann; K Schwenk; W Krone
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.